Lemus David
- SEC CIK
- 0001717972
No open-market purchases or sales filed in the past year.
Current role at each company
- SLN Silence Therapeutics plcDirectoras of Jan 6, 2026
- SCLX Scilex Holding CoDirectoras of Oct 18, 2024
- SRNE Sorrento Therapeutics, Inc.Directoras of Aug 30, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lemus David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SCLX Scilex Holding Co
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2024 (view filing) | Oct 17 | 1 day | Lemus DavidDirector | PPurchase | +2.00K | $0.90 | +$1.80K | New position2.00K after |